AMGN vs HUM
By Alex · Tickerpine
Amgen Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | HUM |
|---|---|---|
| Price | $358.33 | $383.84 |
| Market cap | $193.39B | $46.08B |
| P/E ratio | 24.9 | 41.0 |
| ROE | 101.32% | 6.28% |
| Profit margin | 20.96% | 0.82% |
| Revenue growth | 5.80% | 23.50% |
| Dividend yield | 2.81% | 0.92% |
| Beta | 0.42 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs HUM in plain English
- AMGN is the bigger company — about 4.2× the market cap of HUM.
- AMGN is cheaper on earnings (P/E 24.9 vs 41.0).
- AMGN earns a higher return on equity (101% vs 6%).
- HUM is growing revenue faster (24% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 0.92%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.